Remi Barbier's most recent trade in Filana Therapeutics Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Filana Therapeutics Inc | Remi Barbier | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 71,428 | 0 | - | - | Stock Option (Right to Buy) | |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.87 per share. | 24 May 2023 | 71,428 | 782,002 (4%) | 0% | 16.9 | 1,204,990 | Common Stock |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.25 per share. | 24 May 2023 | 47,723 | 734,279 (4%) | 0% | 25.3 | 1,205,006 | Common Stock |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 14,285 | 0 | - | - | Stock Option (Right to Buy) | |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.87 per share. | 24 May 2023 | 14,285 | 390,397 (2%) | 0% | 16.9 | 240,988 | Common Stock |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.25 per share. | 24 May 2023 | 9,545 | 380,852 (2%) | 0% | 25.2 | 241,011 | Common Stock |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2022 | 57,143 | 710,574 (4%) | 0% | 0 | Common Stock | |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.38 per share. | 06 Jun 2022 | 65,368 | 822,437 (4%) | 0% | 23.4 | 1,528,304 | Common Stock |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2022 | 65,368 | 0 | - | - | Common Stock | |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.93 per share. | 06 Jun 2022 | 54,720 | 767,717 (4%) | 0% | 27.9 | 1,528,330 | Common Stock |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 44,791 | 5,209 | - | - | Common Stock | |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.95 per share. | 25 Apr 2022 | 44,791 | 371,443 (2%) | 0% | 0.9 | 42,551 | Common Stock |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 25 Apr 2022 | 4,669 | 376,112 (2%) | 0% | 16.3 | 76,151 | Common Stock |
| Filana Therapeutics Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 4,669 | 0 | - | - | Common Stock |